688076 諾泰生物
按盤價 
62.090 0.000 (0.000%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 9.953 | 7.986 | 6.938 | 8.317 | 13.730 |
| 總資產報酬率 ROA (%) | 6.007 | 5.369 | 5.554 | 6.552 | 9.351 |
| 投入資產回報率 ROIC (%) | 6.549 | 5.879 | 6.009 | 7.142 | 10.102 | 邊際利潤分析 |
| 銷售毛利率 (%) | 67.316 | 60.970 | 57.573 | 55.756 | 58.164 |
| 營業利潤率 (%) | 31.138 | 18.351 | 19.170 | 19.928 | 25.370 |
| 息稅前利潤/營業總收入 (%) | 31.517 | 17.872 | 18.885 | 19.925 | 29.310 |
| 淨利潤/營業總收入 (%) | 27.873 | 16.008 | 18.850 | 16.899 | 21.174 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 108.475 | 119.143 | 84.003 | 103.928 | 82.638 |
| 價值變動淨收益/利潤總額(%) | -1.400 | 1.826 | 14.615 | 2.559 | 4.386 |
| 營業外收支淨額/利潤總額(%) | -0.758 | -9.553 | -1.375 | -2.054 | 1.873 | 償債能力分析 |
| 流動比率 (X) | 1.373 | 1.536 | 1.909 | 4.009 | 1.277 |
| 速動比率 (X) | 1.026 | 1.148 | 1.322 | 3.098 | 0.793 |
| 資產負債率 (%) | 39.719 | 38.282 | 23.685 | 14.958 | 30.779 |
| 帶息債務/全部投入資本 (%) | 32.796 | 29.919 | 15.173 | 6.859 | -- |
| 股東權益/帶息債務 (%) | 197.302 | 224.103 | 545.882 | 1,326.533 | 367.521 |
| 股東權益/負債合計 (%) | 150.126 | 159.820 | 319.750 | 569.371 | 224.269 |
| 利息保障倍數 (X) | 51.363 | 15.938 | -752.242 | 50.102 | 8.482 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 84.863 | 94.334 | 106.360 | 68.995 | 0.000 |
| 存貨周轉天數 (天) | 269.314 | 312.642 | 374.107 | 275.370 | 0.000 |
| 備註： | 即時報價更新時間為 22/08/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
